Ventio receives the Medical Imaging Innovation Award (JFR, Paris, 2022)
The 70th edition of the Journées Francophones de Radiologie Diagnostique et Interventionnelle (JFR) was held from 7 to 10 October in Paris. To support innovative startups in the field of medical imaging, the French Radioloy Society, Médicen, the SNITEM, and the French-Healthcare Association organized the Medcial Imaging Award. This year, the startups selected to compete had a stand in the “Innovation Village” and were invited to present their innovation in front of a jury of experts.
Ventio was awarded the 1st prize for innovation in medical imaging with the commercial launch of the secure workspaces ~.Ventio® cloud and QSMetric™ – research edition, the Quantitative Magnetic Susceptibility (QSM) imaging technology as an advanced brain study tool finally available to provide innovative imaging biomarkers of the central nervous system.
QSM is sensitive to intracerebral iron that accumulates with age and is involved in ferroptosis, a cell death mechanism targeted by new therapies. QSMetric is based on Magnetic Resonance Imaging (MRI), is patent-protected, FDA-cleared and scientifically validated in the study of neurodegenerative, neuroinflammatory and neurovascular diseases as well as neurosurgical applications. This solution for advanced brain research is accessible in SaaS mode and backed by secure cloud workspaces, allowing the processing of sensitive health data in single and multi-centre studies, and interfacing with health data warehouses.
“Ventio’s team is very proud to receive this award, which is a recognition of the innovating project in digital health carried out by the company on behalf of the French community of radiologists, the medical device industry and the health innovation ecosystem. This award will help us to move towards secure cloud computing to see further into the brains of our elders, notably thanks to the excellent research carried out with our academic partners…”, Dr. Ludovic de ROCHEFORT (CEO Founder of Ventio)